NCT01988636View on ClinicalTrials.gov

Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

296

Participants

Timeline

Start Date

October 29, 2013

Primary Completion Date

August 20, 2015

Study Completion Date

August 20, 2015

Conditions
Malaria
Interventions
BIOLOGICAL

PfSPZ Vaccine

Aseptic, purified, vialed, cryopreserved, radiation attenuated NF54 p.falciparum sporozoites produced by Sanaria, Inc.

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

University of Bamako, Bamako

All Listed Sponsors
collaborator

Malaria Research and Training Center, Bamako, Mali

OTHER

collaborator

Sanaria Inc.

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01988636 - Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults | Biotech Hunter | Biotech Hunter